PREMENSTRUAL SYNDROME
Article Sidebar
Main Article Content
Abstract
Premenstrual syndrome (PMS) is a common condition affecting women of reproductive age, characterized by physical, emotional, and behavioral symptoms that occur during the luteal phase of the menstrual cycle. Common manifestations include mood swings, irritability, fatigue, breast tenderness, and bloating. PMS can significantly affect daily activities, social life, and work performance. Early recognition and management, including lifestyle modification, stress reduction, and pharmacological treatment, are essential to improve the quality of life of affected women [1, 2].
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Yonkers KA, O’Brien PM, Eriksson E. Premenstrual syndrome. Lancet. 2008;371(9619):1200–1210.
2.Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder—clinical procedures and research perspectives. Gynecol Endocrinol. 2004;19(6):320–334.
3.Hantsoo L, Epperson CN. Premenstrual dysphoric disorder: epidemiology and treatment. Curr Psychiatry Rep. 2015;17:87.
4.Biggs WS, Demuth RH. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician. 2011;84(8):918–924.
5.Direkvand-Moghadam A, et al. Psychometric properties of the Persian version of the PSST. Iran J Psychiatry. 2013;8(4):165–171.
6.Rapkin AJ, Akopians AL. Evaluation of premenstrual dysphoric disorder. Obstet Gynecol Surv. 2012;67(2):101–112.
7.Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health. 2003;6:203–209.
8.Field A. Discovering Statistics Using IBM SPSS Statistics. 5th ed. Sage Publications; 2018.
9.Halbreich U, Endicott J, et al. Premenstrual dysphoric disorder and premenstrual syndrome: evaluation and treatment. J Psychosom Obstet Gynaecol. 2003;24(2):91–100.
10.Yonkers KA, O’Brien PM. Treatment strategies for PMS and PMDD. J Womens Health. 2012;21(12):1230–1239.
11.Borenstein JE, Dean BB, Endicott J, et al. Health and economic impact of the premenstrual syndrome. J Reprod Med. 2003;48(7):515–524.
12.Mortola JF, Girton L, Beck L. Premenstrual syndrome: prevalence and severity in a community sample. Am J Public Health. 1990;80(11):1401–1404.
13.Bertone-Johnson ER, Hankinson SE, Johnson SR, et al. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents and young women. Arch Womens Ment Health. 2014;17:27–37.
14.Ozgoli G, Goli M, Simbar M. Effect of aerobic exercise on premenstrual syndrome symptoms: a randomized controlled trial. J Sports Med Phys Fitness. 2011;51(3):477–483.
15.Budeiri D, Abu-Heija A, et al. Premenstrual syndrome: risk factors and lifestyle correlates. Clin Exp Obstet Gynecol. 2007;34(1):45–50.